Suraksha Diagnostic IPO

Suraksha Diagnostic Ltd

₹14,280 /34 sharesMinimum Investment

Suraksha Diagnostic IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
--₹441.00₹438.00-₹3.00 (0.68%)

Suraksha Diagnostic IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
29 Nov ‘24 - 3 Dec ‘24₹14,28034₹420 - ₹441
Issue SizeIPO Doc
846.25Cr
RHP PDF

Subscription rate

As of 03 Dec'24, 05:00 PM
Qualified Institutional Buyers1.74x
Non-Institutional Investor1.4x
Retail Individual Investor0.92x
Total1.26x

About Suraksha Diagnostic

Suraksha Diagnostic is a diagnostic chain headquartered in Kolkata. The company provides services such as pathology and radiology testing and medical consultation. Suraksha Diagnostic’s offerings cover routine pathology tests like basic biochemistry and hematology, besides advanced tests such as molecular pathology, histopathology, and specialised biochemistry. Radiology services include basic tests like X-rays and ultrasonography (USG), intermediate and advanced imaging, such as computerised tomography (CT) scans, specialised CT scans, and magnetic resonance imaging (MRI). Apart from this, it provides online and offline consultations. Its polyclinics have doctors across specialities and superspecialities, including cardiology, paediatrics, dermatology, rheumatology, oncology, and nephrology. Suraksha Diagnostic also provides vaccination services with test packages designed for disease prediction and early detection. ;
Founded in
2005
Managing director
Dr. Somnath Chatterjee and Ms. Ritu Mittal
Parent organisation
Suraksha Diagnostic Ltd

Strengths & Financials of Suraksha Diagnostic

Strengths
Risks
Suraksha Diagnostic operates an extensive network comprising a flagship central reference laboratory, eight satellite laboratories (located within diagnostic centres), and 194 customer touchpoints, including 48 diagnostic centres and 146 sample collection centres (primarily franchised), across West Bengal, Bihar, Assam, and Meghalaya as of March 31, 2024.
Three of its laboratories are accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL), and two advanced diagnostic centres hold accreditation from the National Accreditation Board for Hospitals & Healthcare Providers (NABH).
As of March 31, 2024, 43 diagnostic centres include 120 polyclinic chambers that host over 750 specialised doctors, providing patients with access to expert medical care.
The company offers a comprehensive portfolio of over 2,300 diagnostic tests across various specialities and disciplines. These services are available alongside omnichannel medical consultations, both online and offline, at 43 diagnostic centres equipped with 120 polyclinic chambers.
Suraksha Diagnostic employs a cluster-based 'hub-and-spoke' model. The company claims that this has helped them enhance cost efficiency, standardise testing procedures, and implement deeper brand penetration, especially in remote areas.
Suraksha Diagnostic is accredited by the College of American Pathologists (CAP) and is ISO-certified. The internationally recognised CAP accreditation helps laboratories meet the standards required for ISO 15189 certification, which is tailored for medical laboratories.

Suraksha Diagnostic Financials

*All values are in Rs. Cr
No Graph Data To Display

Application Details of Suraksha Diagnostic IPO

Apply asPrice bandApply upto
Regular420 - 441₹2 Lakh
High Networth Individual420 - 441₹2 - 5 Lakh
For Suraksha Diagnostic IPO, eligible investors can apply as Regular.
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW